LOGIN  |  REGISTER
Cue Biopharma
Terns Pharmaceuticals

Streamline Health® Announces New RevID™ Contract With Georgia-Based Healthcare Provider

September 27, 2023 | Last Trade: US$5.33 0.00 0.00
  • 68-bed Georgia-based healthcare provider selected RevID’s automated charge reconciliation to help eliminate revenue leakage
  • Closed in collaboration with large channel partner

Atlanta, GA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID, with a 68-bed, healthcare provider serving southern Georgia. The contract was the second to close in collaboration with one of Streamline’s large channel partners since June of 2023.

Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID’s automated charge reconciliation ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide.

“We are pleased to support the revenue cycle of another healthcare provider, and that our large channel partner is generating sales momentum,” stated Ben Stilwill, President, Streamline Health. “We look forward to the continued expansion of our client-base to help our nation’s hospitals put an end to lost revenue.”

About Streamline Health

Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net

To Learn More

Media
David Kosloski
Vice President, Marketing & Communications
651.308.1395
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investors
Jacob Goldberger
Director, Investor Relations and FP&A
303.887.9625
This email address is being protected from spambots. You need JavaScript enabled to view it.

Recursion

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page